ITMCTR2000003298
Recruiting
Phase 1
A multicenter randomized controlled clinical study of Fuzheng Xiaoji pill in the treatment of metastatic pancreatic cancer
ConditionsPancreatic cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Pancreatic cancer
- Sponsor
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients over 18 years old;
- •2\. There is definite histopathological or cytological pathological diagnosis. The TNM stage of AJCC pancreatic cancer is stage IV, or combined with the history, clinical manifestations, laboratory examination and imaging examination, the preliminary clinical diagnosis should be made carefully after discussion by MDT, and the evaluable metastatic pancreatic duct adenocarcinoma that has not received chemotherapy in the past;
- •3\. Patients with ECoG score of 0\-2, referring to Zps standard of Eastern Cooperative Oncology Group (Zps);
- •4\. Adequate bone marrow function (granulocyte count \>\= 1500 / m3, platelet count \>\= 100000 / m3\), liver function (bilirubin \<\=1\.5 times the upper limit of normal range) and renal function.
Exclusion Criteria
- •1\. Patients over 76 years old;
- •2\. Patients with pancreatic endocrine tumor, acinar epithelial tumor, mature teratoma, mesenchymal tumor, malignant lymphoma and secondary tumor;
- •3\. The assessable lesions had received radiotherapy, brain metastasis, other malignant tumors, active infection, chronic diarrhea, history of heart with significant clinical impact, pregnancy or lactation;
- •4\. Patients known to be allergic to the study drug;
- •5\. Patients undergoing other drug trials.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
A multicenter randomized controlled clinical study of Yinlai Decoction in the treatment of children with influenza (pulmonary and gastric heat accumulation syndrome)influenzaITMCTR2100005417Beijing University of Chinese Medicine
Recruiting
Phase 1
A multicenter randomized controlled clinical study of Qishao Tianxin prescription in the treatment of early urinary incontinence after radical prostatectomy for prostate cancer.rinary incontinenceITMCTR2100004503Beijing Chaoyang Hospital, Capital Medical University
Not yet recruiting
Phase 1
A multicenter randomized controlled clinical study of Chuanhuang prescription combined with reduced glutathione regimen in the treatment of patients with 1-2 grade AKI on the basis of 2-4 stage CKD and its clinical evaluation of early diagnostic markersITMCTR2000003617Shanghai Municipal Hospital of Traditional Chinese Medicine
Not yet recruiting
Not Applicable
A randomized controlled multicenter clinical trial of Xinxinfu combined with Qiangxin Fang in the treatment of coronary heart disease complicated with cardiac insufficiencyITMCTR2000003805Shanghai Municipal Hospital of Traditional Chinese Medicine
Not yet recruiting
Phase 1
A multicenter randomized controlled clinical trial for 'Sanhuangfu Kang Oil' on acute radiation-induced skin lesions in patients with breast cancerBreast cancerITMCTR1900002612The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine